Pityriasis lichenoides et varioliformis acuta in HIV-1+ patients: A marker of early stage disease

International Journal of Dermatology

Volumn 36, Issue 2, 1997, Pages 104-109

  Smith, Kathleen J ^b   Nelson, Ann ^b   Skelton, Henry ^a   Yeager, Josef ^b   Wagner, Kenneth F ^b  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; MARKER;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; PHENOTYPE; PITYRIASIS LICHENOIDES; SKIN BIOPSY;

EID: 0030896521     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1997.00006.x     Document Type: Article

References (23)

1. Longley J, Demar L, Feinstein RP, et al. Clinical and histologic features of pityriasis lichenoides et varioliformis acuta in children. Arch Dermatol 1987; 123: 1335-1339.
2. Black MM, Marks R. The inflammatory reaction in pityriasis lichenoides. Br J Dermatol 1972; 87: 533-539.
3. Muhlbauer JE, Bahn AK, Harrist TJ, et al. Immunopathology of pityriasis lichenoides acuta. J Am Acad Dermatol 1984; 10: 783-795.
4. Hood AF, Mark EJ. Histopathologic diagnosis of pityriasis lichenoides et varioliformis acuta and its clinical correlation. Arch Dermatol 1982; 118: 478-482.
5. Weiss LM, Wood GS, Ellisen LW, et al. Clonal T-cell populations in pityriasis lichenoides et varioliformis acuta (Mucha-Habermann Disease). Am J Pathol 1987; 126: 417-421.
6. Edwards BL, Bonagura VR, Valacer DJ, Ilowite NT. Mucha-Habermann's disease and arthritis: possible association with reactivated Epstein-Barr virus infection. J Rheumatol 1989; 16: 387-389.
7. Takahashi K, Atsumi M. Pityriasis lichenoides chronica resolving after tonsillectomy. Br J Dermatol 1993; 129: 353-354.
8. Rongioletti F, Rivera G, Rebora A. Pityriasis lichenoides et varioliformis acuta and acquired toxoplasmosis. Dermatologica 1987; 175: 41-44.
9. Clayton R, Haffenden G. An immunofluorescence study of pityriasis lichenoides. Br J Dermatol 1978; 99: 491-493.
10. Clayton R, Haffenden G, du Vivier A, et al. Pityriasis lichenoides - an immune complex disease. Br J Dermatol 1977; 97: 629-634.
11. Faber WR, van Joost T. Pityriasis lichenoides, an immune complex disease? Acta Derm Venereal (Stockh) 1980; 60: 259-261.
12. Thivolet J, Faure M, Chouvet B. Immunofluorescence study of pityriasis lichenoides. Br J Dermatol 1979; 101: 137-2-39.
13. Goodglick L, Braun J. Revenge of the microbes: superantigens of the T and B cell lineage. Am J Pathol 1994; 144: 623-636.
14. Scherer MT, Ignatowiez L, Winslow GM, et al. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu Rev Cell Biol 1993; 9: 101-128.
15. Ostlere LS, Langtry JAA, Branfoot AC, Staughton RCD. HIV seropositivity in association with pityriasis lichenoides et varioliformis acuta. Clin Exp Dermatol 1992; 17: 36-37.
16. Lopez-Estebaranz JL, Vanaclocha F, Gil R, et al. Febrile ulceronecrotic Mucha-Habermann disease. J Am Acad Dermatol 1993; 29: 903-906.
17. Fink-Puches R, Soyer HP, Kerl H. Febrile ulceronecrotic pityriasis lichenoides et varioliformis acuta. J Am Acad Dermatol 1994; 30: 261-263.
18. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994; 15: 575-581.
19. Nickoloff BJ, Mitra RS, Green J, et al. Activated keratinocytes present bacterial-derived superantigen to T lymphocytes: relevance to psoriasis. J Dermatol Sci 1993; 6: 127-133.
20. Sunstedt A, Dohlsten M, Hedlund G, et al. Superantigens anergize cytokine production but not cytotoxicity in vivo. Immunology 1994; 82: 117-125.
21. Varga FJ, Vonderheid EC, Olbricht SM, Kadin ME. Immunohistochemical distinction of lymphomatoid papulosis and pityriasis lichenoides et varioliformis acuta. Am J Pathol 1990; 136: 979-987.
22. Dunn DA, Gadenne A, Simha S, et al. T-cell receptor V-beta expression in normal human skin. Proc Natl Acad Sci USA 1993; 90: 1267-1271.
23. Ohmen JD, Moy RL, Zovich D, et al. Selective accumulation of T cells according to T-cell receptor Vbeta gene usage in skin cancer. J. Invest Dermatol 1994; 103: 751-757.